Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Novel imaging techniques reshape the landscape in high-risk prostate cancers.

Lecouvet FE, Lhommel R, Pasoglou V, Larbi A, Jamar F, Tombal B.

Curr Opin Urol. 2013 Jul;23(4):323-30. doi: 10.1097/MOU.0b013e328361d451. Review.

PMID:
23619580
[PubMed - indexed for MEDLINE]
2.

The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis.

Umbehr MH, Müntener M, Hany T, Sulser T, Bachmann LM.

Eur Urol. 2013 Jul;64(1):106-17. doi: 10.1016/j.eururo.2013.04.019. Epub 2013 Apr 19. Review.

PMID:
23628493
[PubMed - indexed for MEDLINE]
3.

Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?

Lecouvet FE, El Mouedden J, Collette L, Coche E, Danse E, Jamar F, Machiels JP, Vande Berg B, Omoumi P, Tombal B.

Eur Urol. 2012 Jul;62(1):68-75. doi: 10.1016/j.eururo.2012.02.020. Epub 2012 Feb 17.

PMID:
22366187
[PubMed - indexed for MEDLINE]
4.

[PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer].

García JR, Soler M, Blanch MA, Ramírez I, Riera E, Lozano P, Pérez X, Delgado E, Carrio I, Lomeña F.

Rev Esp Med Nucl. 2009 May-Jun;28(3):95-100. Spanish.

PMID:
19558948
[PubMed - indexed for MEDLINE]
5.

18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent.

Tilki D, Reich O, Graser A, Hacker M, Silchinger J, Becker AJ, Khoder W, Bartenstein P, Stief CG, Loidl W, Seitz M.

Eur Urol. 2013 May;63(5):792-6. doi: 10.1016/j.eururo.2012.08.003. Epub 2012 Aug 10.

PMID:
22902037
[PubMed - indexed for MEDLINE]
6.

The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.

Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I.

J Nucl Med. 2006 Feb;47(2):287-97.

PMID:
16455635
[PubMed - indexed for MEDLINE]
Free Article
7.

Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.

Kjölhede H, Ahlgren G, Almquist H, Liedberg F, Lyttkens K, Ohlsson T, Bratt O.

BJU Int. 2012 Nov;110(10):1501-6. doi: 10.1111/j.1464-410X.2012.11123.x. Epub 2012 Apr 13.

PMID:
22502982
[PubMed - indexed for MEDLINE]
8.

Positron emission tomography for prostate, bladder, and renal cancer.

Schöder H, Larson SM.

Semin Nucl Med. 2004 Oct;34(4):274-92. Review.

PMID:
15493005
[PubMed - indexed for MEDLINE]
9.

18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy.

Vees H, Buchegger F, Albrecht S, Khan H, Husarik D, Zaidi H, Soloviev D, Hany TF, Miralbell R.

BJU Int. 2007 Jun;99(6):1415-20. Epub 2007 Apr 8.

PMID:
17428249
[PubMed - indexed for MEDLINE]
10.

Imaging of prostate cancer.

Akin O, Hricak H.

Radiol Clin North Am. 2007 Jan;45(1):207-22. Review.

PMID:
17157630
[PubMed - indexed for MEDLINE]
11.

[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.

Poulsen MH, Bouchelouche K, Høilund-Carlsen PF, Petersen H, Gerke O, Steffansen SI, Marcussen N, Svolgaard N, Vach W, Geertsen U, Walter S.

BJU Int. 2012 Dec;110(11):1666-71. doi: 10.1111/j.1464-410X.2012.11150.x. Epub 2012 Apr 23.

PMID:
22520686
[PubMed - indexed for MEDLINE]
12.

Advances in imaging in the postoperative patient with a rising prostate-specific antigen level.

Hricak H, Schöder H, Pucar D, Lis E, Eberhardt SC, Onyebuchi CN, Scher HI.

Semin Oncol. 2003 Oct;30(5):616-34. Review.

PMID:
14571410
[PubMed - indexed for MEDLINE]
13.

Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).

Panebianco V, Sciarra A, Lisi D, Galati F, Buonocore V, Catalano C, Gentile V, Laghi A, Passariello R.

Eur J Radiol. 2012 Apr;81(4):700-8. doi: 10.1016/j.ejrad.2011.01.095. Epub 2011 Feb 17.

PMID:
21330082
[PubMed - indexed for MEDLINE]
14.

Imaging of castration-resistant prostrate cancer: development of imaging response biomarkers.

Morisson C, Jeraj R, Liu G.

Curr Opin Urol. 2013 May;23(3):230-6. doi: 10.1097/MOU.0b013e32835e9edc. Review.

PMID:
23422587
[PubMed - indexed for MEDLINE]
15.

¹⁸F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers.

Withofs N, Grayet B, Tancredi T, Rorive A, Mella C, Giacomelli F, Mievis F, Aerts J, Waltregny D, Jerusalem G, Hustinx R.

Nucl Med Commun. 2011 Mar;32(3):168-76. doi: 10.1097/MNM.0b013e3283412ef5.

PMID:
21076343
[PubMed - indexed for MEDLINE]
16.

Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.

Schilling D, Schlemmer HP, Wagner PH, Böttcher P, Merseburger AS, Aschoff P, Bares R, Pfannenberg C, Ganswindt U, Corvin S, Stenzl A.

BJU Int. 2008 Aug;102(4):446-51. doi: 10.1111/j.1464-410X.2008.07592.x. Epub 2008 Apr 11.

PMID:
18410442
[PubMed - indexed for MEDLINE]
17.

Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.

Scattoni V, Picchio M, Suardi N, Messa C, Freschi M, Roscigno M, Da Pozzo L, Bocciardi A, Rigatti P, Fazio F.

Eur Urol. 2007 Aug;52(2):423-9. Epub 2007 Mar 20.

PMID:
17397992
[PubMed - indexed for MEDLINE]
18.

Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer.

Morris MJ, Akhurst T, Osman I, Nunez R, Macapinlac H, Siedlecki K, Verbel D, Schwartz L, Larson SM, Scher HI.

Urology. 2002 Jun;59(6):913-8.

PMID:
12031380
[PubMed - indexed for MEDLINE]
19.

[Rational imaging in locally advanced prostate cancer].

Beissert M, Lorenz R, Gerharz EW.

Urologe A. 2008 Nov;47(11):1405-16. doi: 10.1007/s00120-008-1720-7. Review. German.

PMID:
18797837
[PubMed - indexed for MEDLINE]
20.

18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.

Beheshti M, Imamovic L, Broinger G, Vali R, Waldenberger P, Stoiber F, Nader M, Gruy B, Janetschek G, Langsteger W.

Radiology. 2010 Mar;254(3):925-33. doi: 10.1148/radiol.09090413.

PMID:
20177103
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk